NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
RecruitingN/A
Sponsor: AstraZeneca
Conditions: Type 2 Diabetes, Hypertension, Chronic Kidney Disease, Heart Failure
Countries: Brazil, Chile, Costa Rica, Côte d’Ivoire, Egypt, Georgia, Ghana, Hong Kong
To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases
Eligibility overview
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: OBSERVATIONAL
Eligibility criteria
Inclusion Criteria: 1. Being 18 years or older 2. Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease 3. Providing written informed consent to participate in the registry Exclusion Criteria: 1. Having a life-threatening co-morbidity with life expectancy below 1 year 2. Participating in an interventional trial requiring informed consent
Locations (76)
- Fortaleza, Ceará, Brazil
- Colatina, Espírito Santo (ES), Brazil
- Salvador, Estado de Bahia, Brazil
- Brasília, Federal District, Brazil
- Poços de Caldas, Minas Gerais, Brazil
- Campina Grande do Sul, Paraná, Brazil
- Curitiba, Paraná, Brazil
- Teresina, Piauí (PI), Brazil
- Santa Cruz do Sul, Rio Grande Do Sul (RS), Brazil
- Goiânia, State of Goias, Brazil
- Joinville, State of Santa Catarina, Brazil
- Bragança Paulista, São Paulo, Brazil
- São Caetano do Sul, São Paulo, Brazil
- São Paulo, Brazil
- São Paulo, Brazil
- Providencia, Santiago Metropolitan, Chile
- San José, Costa Rica
- Abidjan, Côte d’Ivoire
- Alexandria, Egypt
- Cairo, Egypt
- Giza, Egypt
- Tbilisi, Georgia
- Kumasi, Ghana
- Wan Chai, Hong Kong
- Ahmedabad, India
- Kolkata, India
- Mumbai, India
- Sulaymaniyah, Iraq
- Aktobe, Kazakhstan
- Almaty, Kazakhstan
- + 46 more on CT.gov